Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
S. Sorella
Institution:
Sapienza University of Rome
Observed institutions:
Policlinico Umberto I,
Sapienza University of Rome
ORCID:
0009-0009-6893-257X
Observed ORCID:
0009-0009-6893-257X
OpenAlex ID:
A5042582598
Baseline, Drug‐Related and Persistent Anemia and/or Thrombocytopenia Predict Responses and Prognosis in Myelofibrosis Patients Treated With Ruxolitinib
2025
·
A. Laganà
, E. Scalzulli
, et al.
·
Hematological Oncology
·
4
PDF
A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD
2024
·
S. Sorella
, G. M. Assanto
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
1
Extended anticoagulation with DOACs in patients affected by hematologic malignancies and venous thromboembolism: a monocentric experience
2026
·
M. Biglietto
, S. Sorella
, et al.
·
Journal of Thrombosis and Thrombolysis
P29 | Platelet Aggregation and Thrombin Generation in Multiple Myeloma: a Prospective Study
2026
·
M. Biglietto
, R. Mormile
, et al.
·
Haematologica
PDF
731 | BRENTUXIMAB VEDOTIN (Bv) + Avd IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA: AN ITALIAN REAL‐LIFE MULTICENTRIC STUDY
2025
·
G. M. Assanto
, S. Sorella
, et al.
·
Hematological Oncology
PDF
Author response for "Baseline, Drug‐Related and Persistent Anemia and/or Thrombocytopenia Predict Responses and Prognosis in Myelofibrosis Patients Treated With Ruxolitinib"
2025
·
A. Laganà
, E. Scalzulli
, et al.
·
Publons reviews and discussion
P1362: Feasibility of Haematopoietic Stem Cell Mobilization After Consolidation With Gemtuzumab Ozogamicin and Intermediate-doses Ara-c and Daunorubicin in Aml
2022
·
S. Perrone
, E. Ortu La Barbera
, et al.
·
HemaSphere
Show more works
View as search
Works count:
7
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type